VanEck Associates’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$157K Buy
119,041
+5,535
+5% +$7.3K ﹤0.01% 1274
2025
Q1
$188K Buy
113,506
+6,722
+6% +$11.1K ﹤0.01% 1240
2024
Q4
$157K Sell
106,784
-597
-0.6% -$878 ﹤0.01% 1246
2024
Q3
$157K Buy
107,381
+1,665
+2% +$2.43K ﹤0.01% 1216
2024
Q2
$132K Sell
105,716
-33,447
-24% -$41.8K ﹤0.01% 1233
2024
Q1
$167K Buy
139,163
+6,228
+5% +$7.47K ﹤0.01% 1198
2023
Q4
$201K Sell
132,935
-17,836
-12% -$27K ﹤0.01% 1168
2023
Q3
$241K Buy
150,771
+9,591
+7% +$15.3K ﹤0.01% 1130
2023
Q2
$306K Sell
141,180
-991
-0.7% -$2.15K ﹤0.01% 1120
2023
Q1
$208K Sell
142,171
-1,993
-1% -$2.92K ﹤0.01% 1160
2022
Q4
$180K Buy
144,164
+2,229
+2% +$2.78K ﹤0.01% 1125
2022
Q3
$268K Sell
141,935
-17,744
-11% -$33.5K ﹤0.01% 984
2022
Q2
$404K Buy
+159,679
New +$404K ﹤0.01% 949
2018
Q4
Sell
-96,668
Closed -$334K 842
2018
Q3
$334K Sell
96,668
-384
-0.4% -$1.33K ﹤0.01% 700
2018
Q2
$456K Sell
97,052
-2,274
-2% -$10.7K ﹤0.01% 682
2018
Q1
$315K Buy
99,326
+6,370
+7% +$20.2K ﹤0.01% 608
2017
Q4
$455K Sell
92,956
-11,795
-11% -$57.7K ﹤0.01% 573
2017
Q3
$719K Buy
104,751
+4,283
+4% +$29.4K ﹤0.01% 521
2017
Q2
$661K Buy
100,468
+16,484
+20% +$108K ﹤0.01% 531
2017
Q1
$672K Buy
83,984
+1,274
+2% +$10.2K ﹤0.01% 551
2016
Q4
$769K Sell
82,710
-10,150
-11% -$94.4K ﹤0.01% 514
2016
Q3
$983K Buy
92,860
+593
+0.6% +$6.28K ﹤0.01% 495
2016
Q2
$862K Sell
92,267
-5,328
-5% -$49.8K ﹤0.01% 486
2016
Q1
$1.01M Buy
97,595
+3,389
+4% +$35.2K 0.01% 446
2015
Q4
$947K Buy
94,206
+9,927
+12% +$99.8K 0.01% 398
2015
Q3
$709K Buy
84,279
+10,767
+15% +$90.6K 0.01% 423
2015
Q2
$1.18M Buy
73,512
+10,584
+17% +$170K 0.01% 405
2015
Q1
$892K Sell
62,928
-4,503
-7% -$63.8K 0.01% 427
2014
Q4
$674K Sell
67,431
-2,620
-4% -$26.2K ﹤0.01% 441
2014
Q3
$596K Buy
70,051
+6,510
+10% +$55.4K ﹤0.01% 460
2014
Q2
$562K Buy
63,541
+253
+0.4% +$2.24K ﹤0.01% 471
2014
Q1
$590K Buy
63,288
+13,131
+26% +$122K ﹤0.01% 426
2013
Q4
$423K Buy
50,157
+35,827
+250% +$302K ﹤0.01% 470
2013
Q3
$126K Buy
+14,330
New +$126K ﹤0.01% 583